Diabetic neuropathy in childhood

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 12, Issue 2, 1999, Pages 154-160

  Donaghue, Kim C ^a   Silink, M ^b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b NONE

Author keywords

Diabetic neuropathy; T1DM

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALDOSE REDUCTASE INHIBITOR; CAPSAICIN; CARBAMAZEPINE; GLUCOSE; INSULIN; MEXILETINE; POLYOL; SEROTONIN UPTAKE INHIBITOR; SORBITOL; TRICYCLIC ANTIDEPRESSANT AGENT;

AUTONOMIC NERVOUS SYSTEM; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE MEASUREMENT; CHILD; DIABETIC FOOT; DIABETIC NEUROPATHY; HEART RATE; HEAT SENSITIVITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; NERVE CONDUCTION; NERVE SPROUTING; PAIN; PATHOGENESIS; PERIPHERAL NERVOUS SYSTEM; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PUPIL REFLEX; REVIEW; VIBRATION;

EID: 0032873852     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. White N.H., Waltman S.R., Krupin T., Santiago J.V.: Reversal of neuropathic and gastrointestinal complications related to diabetes mellitus in adolescents with improved metabolic control. J. Pediatr. 99: 41-45, 1981.
2. Watkins P.J.: Clinical observations and experiments in diabetic neuropathy. Diabetologia 35: 2-11, 1992.
3. Pirart J.: Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1: 168-263, 1978.
4. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329: 977-986, 1993.
5. The DCCT Research Group: Effect of intensive diabetes treatment on the development and progression of long-term complication in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J. Pediatr. 125: 177-188, 1994.
6. Dejgaard A.: Pathophysiology and treatment of diabetic neuropathy. Diabet. Med. 15: 97-112, 1998.
7. Tesfaye S., Stevens L.K., Stephenson J.M., Fuller J.H., Plater M., Ionescu-Tirgoviste C., Nuber A., Pozza G., Ward J.D.: Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 39: 1377-1384, 1996.
8. Maser R.E., Steenkiste A.R., Dorman J.S., Nielsen V.K., Bass E.B., Manjoo Q., Drash A.L., Becker D.J., Kuller L.H., Greene D.A., Orchard T.J.: Epidemiological correlates of diabetic neuropathy: report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 38: 1456-1461, 1989.
9. Consensus statement: Report and recommendations of the San Antonio Conference on Diabetic Neuropathy. Diabetes 37: 1000-1004, 1988.
10. Morley G.M., Moordian A.G., Levine A.S., Morley J.E.: Mechanism of pain in diabetic peripheral neuropathy. Am. J. Med. 77: 79-82, 1984.
11. The DCCT Research Group: Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial. Ann. Neurol. 38: 869-880, 1995.
12. Hyllienmark L., Brismar T., Ludvigsson J.: Subclinical nerve dysfunction in children and adolescents with IDDM. Diabetologia 38: 685-692, 1995.
13. Wiles P.G., Pearce S.M., Rice P.J.S., Mitchell J.M.O.: Vibration perception threshold: Influence of age, height, sex, and smoking, and calculation of accurate centile values. Diabet. Med. 8: 157-161, 1991.
14. Donaghue K.C., Bonney M., Simpson J.M., Schwingshandl J., Fung A.T.W., Howard N.J., Silink M.: Autonomic and peripheral nerve function in adolescents with and without diabetes. Diabet. Med. 10: 664-671, 1993.
15. Davis E.A., Jones T.W., Walsh P., Byrne G.C.: The use of biothesiometry to detect neuropathy in children and adolescents with IDDM. Diabetes Care 20: 1448-1453, 1997.
16. Olsen B.S., Nir M., Kjaer I., Volund A., Mortensen H.B.: Elevated vibration perception threshold in young patients with type 1 diabetes in comparison to nondiabetic children and adolescents. Diabet. Med. 11: 888-892, 1994.
17. Heimans J.J., Bertelsmann F.W., de Beaufort C.E., Faber Y.A., Bruining G.J.: Quantitative sensory examination in diabetic children: assessment of thermal discrimination. Diabet. Med. 4: 251-253, 1987.
18. Hendriksen P.H., OEY P.L., Wieneke G.H., Bravenboer B., Van Huffelen A.C. Subclinical diabetic polyneuropathy: early detection of involvement of different nerve fibre types. J. Neurol. Neurosurg. Psychiatry 56: 509-514, 1993.
19. Dyck P.J., Bushek W., Spring E.M., Karnes J.L., Litchy W.J., O'Brien P.C., Service F.J.: Vibratory and cooling detection thresholds compared with other tests in diagnosing and staging diabetic neuropathy. Diabetes Care 10: 432-440, 1987.
20. Jamal G.A., Hansen S., Weir A.I., Ballantyne J.P.: An automated method for the measurement of thermal thresholds: normal subjects. J. Neurol. Neurosurg. Psychiatry 48: 354-360, 1985 .
21. Ewing D.J., Martyn C.N., Young R.J., Clarke B.F.: The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 8: 491-498, 1985.
22. Donaghue K.C., Fung A.T.W., Fairchild J.M., Howard N.J., Silink M.: Prospective assessment of autonomic and peripheral nerve function in adolescents with diabetes. Diabet. Med. 13: 65-71, 1996.
23. Donaghue K.C.: Autonomic neuropathy: diagnosis and impact on health in adolescents with diabetes. Horm. Res. 50: 33-37, 1998.
24. Khan N., Couper J.J.: Diurnal variation of blood pressure in adolescents with type 1 diabetes: dippers and non-dippers. Diabet. Med. 13: 531-535, 1996.
25. Wawryk A.M., Bates D.J., Couper J.J.: Power spectral analysis of heart rate variability in children and adolescents with IDDM. Diabetes Care 20: 1416-1421, 1997.
26. Poulsen P.L., Hansen K.W., Mogensen C.E.: Ambulatory blood pressure in the transition from normo-to-microalbuminuria: a longitudinal study in IDDM patients. Diabetes 43: 1248-1253, 1994.
27. Tanaka H., Hyllienmark L., Thulesius O., Brismar T., Ludvigsson J., Ericson M.O., Lindblad L.E., Tamai H.: Autonomic function in children with type 1 diabetes mellitus. Diabet. Med. 15: 402-411, 1998.
28. Schwingshandl J., Simpson J., Donaghue K., Bonney M., Howard N.J., Silink M.: Pupillary abnormalities in type 1 diabetes occurring during adolescence: Comparison with cardiovascular reflexes. Diabetes Care 16: 630-633, 1993.
29. Pena M.M., Donaghue K.C., Fung A.T.W., Bonney M., Schwingshandl J., Howard N.J., Silink M.: The prospective assessment of autonomic nerve function by pupillometry in adolescents with type 1 diabetes mellitus. Diabet. Med. 12: 868-873, 1995.
30. Karachaliou F.H., Karavanaki K., Greenwood R., Morgan H., Baum J.D.: Consistency of microvascular and autonomic abnormalities in diabetes. Arch. Dis. Child. 75: 124-128, 1996.
31. Ziegler D., Mayer P., Muhlen H., Gries F.A.: The natural history of somatosensory and autonomic nerve dysfunction in relation to glycaemic control during the first 5 years after diagnosis of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 34: 822-829, 1991.
32. The DCCT Research Group: Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in Feasibility Phase of DCCT. Diabetes 37: 476-481, 1988.
33. Forrest K.Y., Maser R.E., Pambianco G., Becker D.J., Orchard T.J.: Hypertension as a risk factor for diabetic neuropathy. Diabetes 46: 665-670, 1997.
34. Dyck P.J., Kratzz K.M., Karnes J.L.. Litchy W.J., Klein R., Pach J.M., Wilson D.M., O'Brien P.C., Melton L.J. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 43: 817-824, 1993.
35. Coppini D.V., Young P.J., Weng C., Macleod A.F., Sonksen P.H.: Outcome on diabetic foot complications in relation to clinical examination and quantitative sensory testing: a case-control study. Diabet. Med. 15: 765-771, 1998.
36. Young M.J., Breddy J.L., Veves A., Boulton A.J.M.: The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. Diabetes Care 17: 557-560, 1994.
37. Ewing D.J., Campbell I.W., Clarke B.F.: The natural history of diabetic autonomie neuropathy. Q. J. Med. 93: 95-108, 1980.
38. Rathman W., Ziegler D., Jahnke M., Haastert B., Gries F.A.: Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet. Med. 10: 820-824, 1993.
39. Sampson M.J., Wilson S., Karagiannis P., Edmonds M., Watkins P.J.: Progression of diabetic autonomic neuropathy over a decade in Insulin-dependent diabetics. Q. J. Med. 278: 635-646, 1990.
40. Page M.Mc.B., Watkins P.J.: Cardiorespiratory arrest and diabetic autonomic neuropathy. Lancet 1: 14-16, 1978.
41. Steel J.M., Young R.J., Lloyd C.G., Clark B.F.: Clinically apparent eating disorders in young diabetic women: associations with painful neuropathy and other complications. B.M.J. 294: 859-862, 1987.
42. Yeap B.B., Russo A., Fraser R.J., Wittert G.A., Horowitz M.: Hyperglycemia affects cardiovascular autonomic nerve function in normal subjects. Diabetes Care 19: 880-882, 1996.